$OMDA

Gracey Craig sold $120K of OMDA

Gracey Craig (Chief Accounting Officer) sold 6,894 shares of Omada Health, Inc. (OMDA) at $17.42 ($0.12M total) on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Jun 16, 2026, 8:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

This provides a fresh, primary-source datapoint on officer ownership changes, but the 10b5-1 designation reduces interpretive weight.

02

Market read

Traders may note the insider sale for sentiment/positioning, but it is unlikely to be a standalone fundamental catalyst.

03

What to watch

The filing date (6/16) may drive a brief sentiment reaction, but the economic substance is the pre-arranged nature and relatively small transaction size.

Relevance 3/10Novelty 6/10Timing: Filed 2026-06-16; sale dated 2026-06-12.

Background

The article is an SEC Form 4 insider transaction disclosure for Omada Health, Inc.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Gracey Craig sold 6,894 shares in an open-market transaction worth about $120.1K under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale; any reaction would be short-lived.

Evidence & confidence

The disclosure is a standard officer sale with a stated pre-arranged 10b5-1 plan and modest dollar value relative to typical market impact.

Market effects

Minimal—this is company-specific insider transaction data with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with management’s view of near-term risk or liquidity needs; traders may watch for follow-on sales.

Key entities

  • Omada Health, Inc.

    Company whose officer transaction is disclosed on SEC Form 4.

  • Gracey Craig

    Chief Accounting Officer who sold shares.

Related articles

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom